Andrew Moody
Physician Assistant · East Providence, RINPI 1720426646
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.3% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $26.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- AbbVie$2K
- AstraZeneca$1K
- Nestle Healthcare Nutrition Inc.$831
- GSK$660
- Biohaven Pharmaceuticals, Inc.$575
- plus $3K from 26 others
What the payments were for
- Speaking & faculty fees$96010%
- Food & beverage$8,91690%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 52 | $2,055 |
| AbbVie(2 entities) | 81 | $1,735 |
| AstraZeneca | 42 | $1,287 |
| Nestle Healthcare Nutrition Inc. | 35 | $831 |
| GSK | 36 | $660 |
| Biohaven Pharmaceuticals, Inc. | 16 | $575 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $363 |
| Paratek Pharmaceuticals, Inc. | 10 | $336 |
| Amgen | 12 | $297 |
| Phathom Pharmaceuticals, Inc. | 9 | $261 |
| Kowa Pharmaceuticals America, Inc. | 16 | $239 |
| Idorsia Pharmaceuticals US Inc | 10 | $176 |
| Novo Nordisk | 9 | $152 |
| Lilly USA, LLC | 6 | $149 |
| Axsome Therapeutics, Inc. | 2 | $127 |
| Genentech USA, Inc. | 10 | $122 |
| Teva Pharmaceuticals USA, Inc. | 4 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Merz North America, Inc. | 1 | $45 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Abbott | 1 | $26 |
| Exact Sciences | 1 | $25 |
| Biogen | 1 | $25 |
| Bausch Health US, LLC | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Halozyme Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,876 in reported general payments places this provider in the 95th percentile of 481 physician assistant providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $38,163 |
| EliquisApixaban | 28 | $25,841 |
| OzempicSemaglutide | 22 | $20,474 |
| JanuviaSitagliptin Phosphate | 18 | $11,452 |
| FarxigaDapagliflozin Propanediol | 12 | $10,499 |
| JardianceEmpagliflozin | 15 | $8,545 |
| Fluticasone Propionate HfaFluticasone Propionate | 12 | $3,700 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,226 |
| Atorvastatin Calcium | 159 | $1,849 |
| Duloxetine Hcl | 45 | $1,847 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,623 |
| Ventolin HfaAlbuterol Sulfate | 28 | $1,613 |
| Omeprazole | 90 | $1,610 |
| Aripiprazole | 20 | $1,182 |
| LantusInsulin Glargine,hum.Rec.Anlog | 13 | $1,174 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $660 | $38,16357 claims |
| PfizerEliquis | $2,055 | $25,84128 claims |
| Novo NordiskOzempic | $152 | $20,47422 claims |
| AstraZenecaFarxiga | $1,287 | $10,49912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 481 physician assistant providers in Rhode Island.
Other physician assistant in East Providence
- Krista AcciaioliEast Providence$5K
- Andrew RegoEast Providence$4K
- Claudia KaneEast Providence$3K
- Kelsey HayesEast Providence$2K
- Lauren MacchioEast Providence$2K
- Scott SullivanEast Providence$2K
- Mara HarkinsEast Providence$2K
- Jennifer GeremiaCranston$370K
- Stephanie MarlinLincoln$37K
- Thomas BalesProvidence$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.